- Filed
- May 12, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 79.72M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 78.66M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 59.31M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | −$67.66M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$35.14M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $185.92M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $340.24M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $1.08B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $750.11M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $846.25M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $535.31M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $42.44M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $39.75M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $72M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $75.77M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $713.15M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $770.38M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.16B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $825.89M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | −$0.90 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.90 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | −$0.90 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.90 |
| Sga Expense | Q1 2025 · Mar 31, 2025 | $11.32M |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $9.3M |
| Rd Expense | Q1 2025 · Mar 31, 2025 | $69.57M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $50.65M |
| Net Income | Q1 2025 · Mar 31, 2025 | −$70.73M |
| Net Income | Q1 2025 · Dec 31, 2024 | −$252.06M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$53.34M |
| Net Income | Q1 2025 · Dec 31, 2023 | −$151.76M |
| Operating Income | Q1 2025 · Mar 31, 2025 | −$80.88M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$59.95M |